Clinical Trial Update: Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the combination of eptifibatide and bivalirudin with bivalirudin alone in patients with coronary artery disease, assessing peri-proced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Angiomax (bivalirudin)
• Integrilin (Eptifibatide)

Snippet

Sponsor: LifeBridge Health | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN